On the synergy between silver nanoparticles and doxycycline towards the inhibition of: Staphylococcus aureus growth

8Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

In a previous paper (RSC Adv., 2015, 5, 66886-66893), we showed that the combination of silver nanoparticles (NanoAg) with doxycycline (DO) culminated in an increased bactericidal activity towards E. coli. Herein we further investigated the metabolic changes that occurred on Staphylococcus aureus upon exposure to NanoAg with the help of attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) coupled with multivariate data analysis. It has been discovered that the combination of DO with NanoAg produced metabolic changes in S. aureus that were not simply the overlap of the treatments with DO and NanoAg separately. Our results suggest that DO and NanoAg act synergistically to impede protein synthesis by the bacteria.

Cite

CITATION STYLE

APA

Silva, H. F. O., De Lima, R. P., Da Costa, F. S. L., Moraes, E. P., Melo, M. C. N., Sant’Anna, C., … Gasparotto, L. H. S. (2018). On the synergy between silver nanoparticles and doxycycline towards the inhibition of: Staphylococcus aureus growth. RSC Advances, 8(42), 23578–23584. https://doi.org/10.1039/c8ra02176g

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free